Global Patent Index - EP 0917592 A4

EP 0917592 A4 20020424 - ATTENUATED RESPIRATORY SYNCYTIAL VIRUS

Title (en)

ATTENUATED RESPIRATORY SYNCYTIAL VIRUS

Title (de)

ABGESCHWAECHTER RSV

Title (fr)

VIRUS RESPIRATOIRE SYNCYTIAL ATTENUE

Publication

EP 0917592 A4 20020424 (EN)

Application

EP 97920111 A 19970403

Priority

  • US 9705588 W 19970403
  • US 1484896 P 19960404

Abstract (en)

[origin: WO9738138A1] Attenuated respiratory syncytial viruses (RSV) and in particular temperature sensitive RSV are provided. The viruses of the present invention may be used in pharmaceutical compositions such as vaccines. Methods of making and using such pharmaceutical compositions are also provided.

IPC 1-7

C12Q 1/70

IPC 8 full level

A61K 39/155 (2006.01); C07K 14/135 (2006.01); C12N 7/08 (2006.01); A61K 39/00 (2006.01)

CPC (source: EP)

A61K 39/12 (2013.01); A61K 39/155 (2013.01); C07K 14/005 (2013.01); C12N 7/00 (2013.01); A61K 2039/5254 (2013.01); A61K 2039/5256 (2013.01); A61K 2039/543 (2013.01); A61K 2039/545 (2013.01); A61K 2039/55566 (2013.01); A61K 2039/57 (2013.01); C12N 2760/18522 (2013.01); C12N 2760/18534 (2013.01); C12N 2760/18564 (2013.01)

Citation (search report)

  • [X] EP 0567100 A1 19931027 - AMERICAN CYANAMID CO [US]
  • [X] WO 9321310 A1 19931028 - AMERICAN HOME PROD [US], et al
  • [X] US 4122167 A 19781024 - BUYNAK EUGENE B, et al
  • [E] WO 9802180 A1 19980122 - CONNAUGHT LAB [CA], et al
  • [X] CROWE JAMES E JR ET AL: "A further attenuated derivative of a cold-passaged temperature-sensitive mutant of human respiratory syncytial virus retains immunogenicity and protective efficacy against wild-type challenge in seronegative chimpanzees.", VACCINE, vol. 12, no. 9, 1994, pages 783 - 790, XP001021054, ISSN: 0264-410X
  • [Y] CROWE J E ET AL: "A COMPARISON IN CHIMPANZEES OF THE IMMUNOGENICITY AND EFFICACY OF LIVE ATTENUATED RESPIRATORY SYNCYTIAL VIRUS (RSV) TEMPERATURE-SENSITIVE MUTANT VACCINES AND VACCINIA VIRUS RECOMBINANTS THAT EXPRESS THE SURFACE GLYCOPROTEINS OF RSV", VACCINE, BUTTERWORTH SCIENTIFIC. GUILDFORD, GB, vol. 11, no. 14, 1993, pages 1395 - 1404, XP002910146, ISSN: 0264-410X
  • [X] HSU K-H L ET AL: "Isolation and characterization of a highly attenuated respiratory syncytial virus (RSV) vaccine candidate by mutagenesis of the incompletely attenuated RSV A2 ts-1 NG-1 mutant virus", VACCINE, BUTTERWORTH SCIENTIFIC. GUILDFORD, GB, vol. 13, no. 5, 1995, pages 509 - 515, XP004057727, ISSN: 0264-410X
  • [X] MURPHY B R ET AL: "AN UPDATE ON APPROACHES TO THE DEVELOPMENT OF RESPIRATORY SYNCYTIAL VIRUS (RSV) AND PARAINFLUENZA VIRUS TYPE 3 (PIV3) VACCINES", VIRUS RESEARCH, AMSTERDAM, NL, vol. 32, 1994, pages 13 - 36, XP002910147, ISSN: 0168-1702
  • [Y] WRIGHT P F ET AL: "ADMINISTRATION OF A HIGHLY ATTENUATED, LIVE RESPIEATORY SYNCYTIAL VIRUS VACCINE TO ADULTS AND CHILDREN", INFECTION AND IMMUNITY, AMERICAN SOCIETY FOR MICROBIOLOGY. WASHINGTON, US, vol. 37, no. 1, 1 July 1982 (1982-07-01), pages 397 - 400, XP002910148, ISSN: 0019-9567
  • [X] EWASYSHYN M ET AL: "PROSPECTS FOR IMMUNIZATION AGAINST RESPIRATORY SYNCYTIAL VIRUS", VACCINE RESEARCH, MARY ANN LIEBERT, INC., PUBLISHERS, US, vol. 2, no. 4, 1993, pages 263 - 272, XP002044888
  • [Y] MAASSAB H F ET AL: "DEVELOPMENT AND CHARACTERIZATION OF COLD-ADAPTED VIRUSES FOR USE AS LIVE VIRUS VACCINES", VACCINE, BUTTERWORTH SCIENTIFIC. GUILDFORD, GB, vol. 3, 1 December 1985 (1985-12-01), pages 355 - 369, XP002910149, ISSN: 0264-410X
  • [X] CONNORS MARK ET AL: "A cold-passaged attenuated strain of human respiratory syncytial virus contains mutations in the F and L genes.", VIROLOGY, vol. 208, no. 2, 1995, pages 478 - 484, XP002047454, ISSN: 0042-6822
  • [X] CROWE J E: "CURRENT APPROACHES TO THE DEVELOPMENT OF VACCINES AGAINST DISEASE CAUSED BY RESPIRATORY SYNCYTIAL VIRUS (RSV) AND PARAINFLUENZA VIRUS(PIV)", VACCINE, BUTTERWORTH SCIENTIFIC. GUILDFORD, GB, vol. 13, no. 4, 1995, pages 415 - 421, XP002028713, ISSN: 0264-410X
  • [A] STOKES A ET AL: "The complete nucleotide sequence of two cold-adapted, temperature-sensitive attenuated mutant vaccine viruses (cp12 and cp45) derived from the JS strain of human parainfluenza virus type 3 (PIV3).", VIRUS RESEARCH, (1993 OCT) 30 (1) 43-52., XP002051711
  • [T] HERLOCHER M L ET AL: "Immunological properties of plaque purified strains of live attenuated respiratory syncytial virus ( RSV ) for human vaccine.", VACCINE, (1999 JAN) 17 (2) 172-81., XP004139973
  • See references of WO 9738138A1

Designated contracting state (EPC)

AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

DOCDB simple family (publication)

WO 9738138 A1 19971016; AU 2438597 A 19971029; CA 2250883 A1 19971016; EP 0917592 A1 19990526; EP 0917592 A4 20020424

DOCDB simple family (application)

US 9705588 W 19970403; AU 2438597 A 19970403; CA 2250883 A 19970403; EP 97920111 A 19970403